Drawing for GERI

USPTO serial 79178137

GERI

Reviewed by CopyMark Law Group

Reg. 5111612Status 706Renewal
Filing date
Status date
Registration date
Jan 3, 2017
Examiner
BRODY, DANIEL S
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with GERI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric Lamb

Eric Lamb FBT Gibbons LLP111 Monument CircleSuite 4500INDIANAPOLIS, IN 46204

Goods and services

ClassDescriptionStatusFirst use
009Scientific and laboratory apparatus, instruments and equipment, namely, incubators and parts and fittings specially designed therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes and being for scientific use; apparatus, instruments and equipment for clinical and medical laboratory use, namely, incubators and parts and fittings specially designed therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes and being for laboratory use; laboratory equipment and supplies, namely, incubators; laboratory equipment and supplies, namely, incubators for scientific use; laboratory equipment and supplies, namely, incubators for scientific and laboratory use in the fields of reproductive science, human fertility, human reproduction and assisted conceptionACTIVE—
010Medical apparatus, instruments and equipment, namely, incubators and parts and fittings specially designed therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; incubators for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2026ES71TEAS SECTION 71 RECEIVED—
Mar 7, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Nov 13, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 9, 2023NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 9, 202371AGREGISTERED-SEC.71 ACCEPTED—
Sep 8, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 20, 2023ES71TEAS SECTION 71 RECEIVED—
Jan 7, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 3, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 15, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 18, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 18, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 22, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 5, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 5, 2017FIMPFINAL DISPOSITION PROCESSED—
Apr 3, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 3, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 18, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 15, 2016DOCKASSIGNED TO EXAMINER—
Oct 18, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 18, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 28, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 28, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 28, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 12, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 3, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 2, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 2, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2016ALIEASSIGNED TO LIE—
Aug 29, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 1, 2016CHLDCHANGE OF OWNER RECEIVED FROM IB—
Mar 18, 2016RFNPREFUSAL PROCESSED BY IB—
Mar 1, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 1, 2016RFRRREFUSAL PROCESSED BY MPU—
Mar 1, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 29, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2016DOCKASSIGNED TO EXAMINER—
Dec 18, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 14, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance